--2025/Q1-- / 433.330K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
CLDX Celldex Therapeutics
- 25.410
- -1.040-3.93%
Close Dec 13 16:00 ET
- 25.410
- 0.0000.00%
Post 16:15 ET
1.69BMarket Cap-9.85P/E (TTM)
26.620High24.480Low1.04MVolume26.260Open26.450Pre Close26.37MTurnover1.66%Turnover RatioLossP/E (Static)66.34MShares53.18052wk High2.15P/B1.59BFloat Cap22.92952wk Low--Dividend TTM62.70MShs Float3374.997Historical High--Div YieldTTM8.09%Amplitude1.500Historical Low25.353Avg Price1Lot Size
Celldex Therapeutics Key Stats
Celldex Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Celldex Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data